The Use of Live Attenuated Influenza Vaccine (LAIV) in Healthcare Personnel (HCP): Guidance from the Society for Healthcare Epidemiology of America (SHEA)

The Use of Live Attenuated Influenza Vaccine (LAIV) in Healthcare Personnel (HCP): Guidance from the Society for Healthcare Epidemiology of America (SHEA)

Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection control and hospital epidemiology 2012-10, Vol.33 (10), p.981-983
Hauptverfasser: Talbot, Thomas R., Babcock, Hilary, Cotton, Deborah, Maragakis, Lisa L., Poland, Gregory A., Septimus, Edward J., Tapper, Michael L., Weber, David J.
Format: Artikel
Sprache:eng
Schlagworte:
Adults
Biological and medical sciences
Disease transmission
Epidemiology
Health care administration
Health care industry
Health Personnel
Hospitals
Human viral diseases
Humans
Immunocompromised populations
Infection
Infection control
Infection Control - methods
Infectious diseases
Influenza
Influenza A virus - immunology
Influenza B virus - immunology
Influenza vaccines
Influenza Vaccines - therapeutic use
Influenza, Human - prevention & control
Influenza, Human - virology
Medical sciences
Medical syringes
Miscellaneous
Nursing
Personnel
Practice Guidelines as Topic
Public health. Hygiene
Public health. Hygiene-occupational medicine
SHEA Guidance Statement
United States
Vaccination
Vaccines
Vaccines, Attenuated - therapeutic use
Viral diseases
Viral diseases of the respiratory system and ent viral diseases
Virus Shedding
Viruses
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.
ISSN:0899-823X
1559-6834
DOI:10.1086/667772